My CML app

Two BOPA members, Andrea Preston and Nick Duncan, have just launched a new, free patient support app for CML patients.  They are keen to raise awareness, so please spread the word to patients, your Haematology CNS, and any other colleagues who you think might be interested.

More details and app store links can be found at:
https://mycml.thetechcompany.co.uk/

 

Launch of a new app for CML patients

A new, free patient support app has just been launched and is available to download from the Apple and Google Play app stores.
Created by a team of NHS Pharmacists working closely with CML patient support groups, My CML contains a set of specially designed functions to promote optimal patient outcomes. These include:

A symptom/side effect tracker. You can record how you are feeling on a particular day, either in the form of a diary entry or by recording a score (on a scale of 0-10) for particular symptoms e.g. nausea, diarrhoea, muscle cramps etc.

A drug interaction checker. You can check if there are any interactions between your CML medication and other medications. The app uses a traffic light system to tell you whether there is likely to be an interaction between any two medications and how significant any interaction is likely to be.

The ability to enter key lab test results. You can record important blood test results such as BCR-ABL PCR, full blood count, kidney function and liver function. You can then keep track of your results over time using the tables and graphs in the My Progress section of the app.

A medication reminder tool. You can set a daily reminder to help you remember to take your CML medication (and any other medication that you might take regularly). You can also record every time you take a dose of medication and can then check how good your adherence is using the My Progress function.  This also allows you to generate a graph to share with your healthcare provider.

An appointment diary. This allows you to keep track of all CML-related appointments. It also has a notes function so that you can record any questions or topics that you might want to talk about with your health care provider.

Access to up to date CML information including guidelines, information on medicines and various support groups both for CML and for cancer in general.

More details and app store links can be found at: https://mycml.thetechcompany.co.uk/

Latest News

By BOPA on 12th May 2022

REGISTRATION NOW OPEN – The 25th Annual BOPA Symposium, 7-9 October, Liverpool

An important date for your diaries: The 25th British Oncology Pharmacy Association (BOPA) Annual Symposium (7th – 9th October). Oncology and haematology are ever-changing landscapes and this year we are looking to…

Read article
By BOPA Committee on 11th May 2022

Vote for the 2023 Symposium Venue: PAID members

The BOPA committee are giving all PAID members of BOPA the opportunity to help inform the choice of venue for the 2023 BOPA symposium. If you wish to take part…

Read article
By BOPA Committee on 11th May 2022

PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process. The Draft Guideline can be…

Read article
By BOPA Committee on 11th May 2022

UK Oncology Forum

Dear Colleague Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused. However –…

Read article

25th BOPA Symposium 2022

7th to 9th October 2022 at The ACC Liverpool

REGISTRATION NOW OPEN!
Members: www.bopa.org.uk/2022-members-symposium-link/
Non members: Contact Media1Productions: [email protected]
Please see Key information before for accommodation information.

DRAFT AGENDA
Please click here to view the latest agenda.

CONFERENCE FEES (includes VAT)
Early-bird rate applies up until Monday 22nd August 2022

Everything you need to know